Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 'All In One' SARS-CoV-2 variant recognition platform: Machine learning-enabled point of care diagnostics. | Biosens Bioelectron X | 2022 | 35036904 | PubTator, text mining | PubMed |
| Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality. | Med Microbiol Immunol | 2022 | 35034207 | PubTator, text mining | PubMed |
| Antibodies to watch in 2022. | MAbs | 2022 | 35030985 | PubTator, text mining | PubMed |
| Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells. | iScience | 2022 | 35024587 | PubTator, text mining | PubMed |
| Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study. | Br J Clin Pharmacol | 2022 | 35014061 | PubTator, text mining | PubMed |
| Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. | Nat Commun | 2022 | 35013146 | PubTator, text mining | PubMed |
| The Different Immune Responses by Age Are due to the Ability of the Fetal Immune System to Secrete Primal Immunoglobulins Responding to Unexperienced Antigens. | Int J Biol Sci | 2022 | 35002513 | PubTator, text mining | PubMed |
| Complement cascade inhibition in geographic atrophy: a review. | Eye (Lond) | 2022 | 34999723 | PubTator, text mining | PubMed |
| The renal clear cell carcinoma immune landscape. | Neoplasia | 2022 | 34991061 | PubTator, text mining | PubMed |
| Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. | EBioMedicine | 2022 | 34990893 | PubTator, text mining | PubMed |
| SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway. | Cancer Cell Int | 2022 | 34980127 | PubTator, text mining | PubMed |
| Electrostatic Perturbations in the Substrate-Binding Pocket of Taurine/α-Ketoglutarate Dioxygenase Determine its Selectivity. | Chemistry | 2022 | 34967481 | PubTator, text mining | PubMed |
| Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity. | Adipocyte | 2022 | 34964707 | PubTator, text mining | PubMed |
| Inflammation and convergent placenta gene co-option contributed to a novel reproductive tissue. | Curr Biol | 2022 | 34932936 | PubTator, text mining | PubMed |
| Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation. | Transplantation | 2022 | 34905763 | PubTator, text mining | PubMed |
| Clusterin, other extracellular chaperones, and eye disease. | Prog Retin Eye Res | 2022 | 34896599 | PubTator, text mining | PubMed |
| Automated High-Throughput Method for the Fast, Robust, and Reproducible Enrichment of Newly Synthesized Proteins. | J Proteome Res | 2022 | 34860524 | PubTator, text mining | PubMed |
| The role of complement in the clinical course of hepatocellular carcinoma. | Immun Inflamm Dis | 2022 | 34813686 | PubTator, text mining | PubMed |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. | Biomed Pharmacother | 2022 | 34801852 | PubTator, text mining | PubMed |
| The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function. | Biochim Biophys Acta Mol Cell Biol Lipids | 2022 | 34800735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=44